Takayuki Uematsu
Overview
Explore the profile of Takayuki Uematsu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
31
Citations
365
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Imai M, Kawakami F, Uematsu T, Matsumoto T, Kawashima R, Kurosaki Y, et al.
PLoS One
. 2024 Oct;
19(10):e0312834.
PMID: 39475992
COVID-19, an infectious disease caused by SARS-CoV-2, was declared a pandemic by the WHO in 2020. Psychiatric symptoms including sleep disturbance, memory impairment, and depression are associated with SARS-CoV-2 infection....
2.
Kurosaki Y, Matsumoto T, Uematsu T, Kawakami F, Kawashima R, Tamaki S, et al.
Sci Rep
. 2024 Oct;
14(1):24313.
PMID: 39414885
Patients with coronavirus disease 2019 (COVID-19) often experience acute kidney injury, linked to disease severity or mortality, along with renal tubular dysfunction and megalin loss in proximal tubules. Megalin plays...
3.
Uematsu T, Takai-Todaka R, Haga K, Kobayashi H, Imajima M, Kobayashi N, et al.
J Infect Chemother
. 2024 Aug;
31(1):102505.
PMID: 39197667
Background: Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), remains a global public health threat. Although several effective vaccines and therapeutics have been developed, continuous...
4.
Ando W, Sogabe M, Ishikawa S, Uematsu T, Furuya H, Yokomori H, et al.
Oncol Lett
. 2024 Feb;
27(3):127.
PMID: 38333640
The present study describes a novel molecular-genetic method suitable for lung cancer (LC) screening in the work-place and at community health centers. Using urinary-isolated exosomes from 35 patients with LC...
5.
Yasuoka Y, Izumi Y, Fukuyama T, Oshima T, Yamazaki T, Uematsu T, et al.
Int J Mol Sci
. 2024 Jan;
25(2).
PMID: 38279224
Many large-scale studies show that exogenous erythropoietin, erythropoiesis-stimulating agents, lack any renoprotective effects. We investigated the effects of endogenous erythropoietin on renal function in kidney ischemic reperfusion injury (IRI) using...
6.
Jimbo M, Saito S, Uematsu T, Hanaki H, Otori K, Shibuya K, et al.
BMC Public Health
. 2023 Aug;
23(1):1489.
PMID: 37542210
Background: This study aimed to identify the current risk factors for coronavirus disease 2019 severity and examine its association with medication use. Methods: We used data from a large United...
7.
Uematsu T, Takano T, Matsui H, Kobayashi N, Omura S, Hanaki H
J Antibiot (Tokyo)
. 2023 May;
76(8):481-488.
PMID: 37185581
COVID-19, caused by SARS-CoV-2 infection, is currently among the most important public health concerns worldwide. Although several effective vaccines have been developed, there is an urgent clinical need for effective...
8.
Ando W, Horii T, Jimbo M, Uematsu T, Atsuda K, Hanaki H, et al.
Front Public Health
. 2022 Dec;
10:985494.
PMID: 36504971
Background: We aimed to clarify the relationship between coronavirus disease 2019 (COVID-19) reinfection and basic disease and smoking status. Methods: The electronic health records of 165,320 patients with COVID-19 from...
9.
Yasuoka Y, Izumi Y, Fukuyama T, Omiya H, Pham T, Inoue H, et al.
Molecules
. 2022 Feb;
27(3).
PMID: 35164384
Anemia is a major complication of chronic renal failure. To treat this anemia, prolylhydroxylase domain enzyme (PHD) inhibitors as well as erythropoiesis-stimulating agents (ESAs) have been used. Although PHD inhibitors...
10.
Ando W, Horii T, Uematsu T, Hanaki H, Atsuda K, Otori K
Sci Rep
. 2021 Sep;
11(1):17968.
PMID: 34504112
The impact of overlapping risk factors on coronavirus disease (COVID-19) severity is unclear. To evaluate the impact of type 2 diabetes (T2D) and obesity on COVID-19 severity, we conducted a...